D. Revicki - Publications, H-index & Citations

D. Revicki

Evidera

8H指数

69论文数

465被引数

收录论文 20

发表时间

BREMELANOTIDE TREATMENT PROVIDED CLINICALLY MEANINGFUL BENEFITS IN PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER

JOURNAL OF SEXUAL MEDICINE

IF3.3

2020-01-01

PREAI

Kingsberg, S.; Clayton, A.; Portman, D.; Jordan, R.; Revicki, D.; Williams, L.; Krop, J.

WOMEN'S EXPERIENCES WITH BREMELANOTIDE ADMINISTERED, ON DEMAND, FOR THE TREATMENT OF HYPOACTIVE SEXUAL DESIRE DISORDER

JOURNAL OF SEXUAL MEDICINE

IF3.3

2019-06-01

PREAI

Koochaki, P.; Revicki, D.; Wilson, H.; Pokrzywinski, R.; Jordan, R.; Lucas, J.

BREMELANOTIDE PROVIDES MEANINGFUL TREATMENT BENEFITS FOR PREMENOPAUSAL WOMEN WITH HYPOACTIVE SEXUAL DESIRE DISORDER

JOURNAL OF SEXUAL MEDICINE

IF3.3

2018-07-01

PREAI

Koochaki, P. E.; Revicki, D. A.; Wilson, H.; Pokrzywinski, R.; Jordan, R.; Lucas, J.

THE AMERICAN NEUROGASTROENTEROLOGY AND MOTILITY SOCIETY GASTROPARESIS CARDINAL SYMPTOM INDEX-DAILY DIARY (ANMS GCSI-DD): ASSESSING THE CONTENT VALIDITY IN PATIENTS WITH IDIOPATHIC OR DIABETIC GASTROPARESIS

VALUE IN HEALTH

IF6

2018-05-01

OAAI

Revicki, D. A.; Gleeson, S.; Speck, R.; Puelles, J.; Kuo, B.; Camilleri, M.; Parkman, H. P.

AN ANCHOR-BASED APPROACH TO DEFINE AN IMPAIRED DAY IN MIGRAINE PATIENTS UTILIZING THE MIGRAINE PHYSICAL FUNCTION IMPACT DIARY

VALUE IN HEALTH

IF6

2016-11-01

OAAI

Kawata, A. K.; Hsieh, R.; Sapra, S.; Desai, P. R.; Ortmeier, B. G.; Gleeson, S.; Revicki, D. A.; Lipton, R. B.; Bayliss, M.; Hareendran, A.

SCORING AND RESPONSIVENESS OF THE SELF-ASSESSMENT OF TREATMENT VERSION II QUESTIONNAIRE IN PATIENTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY

VALUE IN HEALTH

IF6

2015-11-01

OAAI

van Houten, F. E.; Trundell, D.; Staniewska, D.; Revicki, D. A.

PATIENT-REPORTED PHYSICAL FUNCTION OUTCOME MEASURE FOR ADULTS WITH FIBRODYSPLASIA OSSIFICANS PROGRESSIVA: INTELLIGENT TEST DESIGN BASED ON PROMIS ITEM BANKS

VALUE IN HEALTH

IF6

2015-05-01

OAAI

Mattera, M. S.; Kaplan, F. S.; Pignolo, R. J.; Grogan, D.; Revicki, D. A.

EMPLOYING MULTI-ATTRIBUTE UTILITY THEORY TO DEVELOP THE EXACT-U: A PREFERENCE-BASED MEASURE FOR COPD EXACERBATION UTILITIES

VALUE IN HEALTH

IF6

2010-11-01

OAAI

Petrillo, J.; Cairns, J.; Revicki, D. A.

FLUSHING ASSESSMENT TOOL (FAST): PSYCHOMETRIC PROPERTIES OF A NEW MEASURE ASSESSING FLUSHING SYMPTOMS

VALUE IN HEALTH

IF6

2009-05-01

OAAI

Kawata, A. K.; Thakkar, R.; Davidson, M. H.; Punzi, H. A.; Jiang, P.; Li, D.; Krause, S.; Padley, R.; Revicki, D. A.

INTERPRETING SCORES ON THREE PATIENT-REPORTED OUTCOME MEASURES FOR ASTHMA

VALUE IN HEALTH

IF6

2008-11-01

OAAI

Meads, D. M.; Twiss, J.; McKenna, S. P.; Revicki, D.; Pokrzywinski, R.; Gale, R.

INTERPRETING SCORES ON THREE COPD PATIENT-REPORTED OUTCOME MEASURES

VALUE IN HEALTH

IF6

2008-11-01

OAAI

McKenna, S. P.; Twiss, J.; Meads, D. M.; Revicki, D.; Pokrzywinski, R.; Gale, R.

Humanistic and economic outcomes associated with negative symptoms in patients with schizophrenia

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2008-08-01

PREAI

Kleinman, L.; Mannix, S.; Leeuwenkamp, O.; Revicki, D.; Velligan, D.

Generalized anxiety disorder: A comprehensive literature review of the burden of illness in North America

VALUE IN HEALTH

IF6

2008-05-01

OAAI

Wyrwich, K.; Mattera, M. S.; Svedsater, H.; Locklear, J. C.; Revicki, D.; Sheehan, D.

Measuring changes in functional status among patients with schizophrenia: The link with cognitive impairment

SCHIZOPHRENIA BULLETIN

IF4.8

2005-10-12

OAAI

Matza, Louis S.; Buchanan, Robert; Purdon, Scot; Brewster-Jordan, Jessica; Zhao, Yang; Revicki, Dennis A.

Reliability and validity of the Readiness for Discharge Questionnaire in schizophrenia

VALUE IN HEALTH

IF6

2005-05-01

OAAI

Ruetsch, C; Rupnow, MF; Revicki, DA; Kosik-Gonzalez, C; Greenspan, A; Gharabawi, G

Patient-rated utilities in postmenopausal early breast cancer (EBC): A cross-country comparison

VALUE IN HEALTH

IF6

2004-11-01

OAAI

Sorensen, SV; Brown, R; Benedict, A; Flood, E; Revicki, D

Development and assessment of health state utilities for attention deficit/hyperactivity disorder in children using parent proxy report

VALUE IN HEALTH

IF6

2003-11-01

OAAI

Matza, LS; Secnik, K; Rentz, AM; Mannix, S; Revicki, DA; Sallee, FR

Patient-valued health state utilities for bipolar disorder: Differences that can be measured

VALUE IN HEALTH

IF6

2003-05-01

OAAI

Hanlon, JT; Mannix, S; Kleinman, L; Martin, S; Revicki, D

A meta-analysis of the efficacy of olanzapine and ziprasidone in treating schizophrenia

SCHIZOPHRENIA RESEARCH

IF3.5

2003-03-01

PREAI

Matza, L; Baker, T; Revicki, DA

Reliability, validity, and scaling of fatigue severity scales for patients with chronic hepatitis C

JOURNAL OF HEPATOLOGY

IF33

2000-01-01

PREAI

Green, J; Kleinman, L; Hakim, Z; Barker, C; Revicki, D

研究方向